-
-
Vector control
Takeda4 minutes -
Surveillance and Reporting
Takeda5 minutes -
Economic Impact of Dengue
Takeda4 minutes -
Dengue global epidemiology
Takeda4 minutes -
Dengue Phases & Guidelines
Takeda4 minutes -
Antibody Levels over Time
Takeda2 minutes -
Dengue infection cycle and clinical spectrum
Takeda2 minutes -
Laboratory diagnostic tests
Takeda -
Differential diagnosis
Takeda1 minutes -
Management of cases
Takeda1 minutes -
Dengue disease states
Takeda4 minutes -
Mechanisms of dengue
Takeda4 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Immune response to dengue virus
Takeda4 minutes -
Dengue virus and pathobiology
Takeda1 minutes -
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Randomised trials of Wolbachia for dengue control – a step towards elimination?
ADVA50 minutes -
Impact of the COVID-19 Pandemic on the Global Dengue Situation
ADVA79 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021